Please Wait
Applying Filters...

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

myNEO Therapeutics is a leading biopharmaceutical firm dedicated to pioneering groundbreaking immunotherapies for cancer treatment. Leveraging its ImmunoEngine platform, the company explores unique tumor targets in the dark genome known as camyotopes™. These camyotopes™ hold the potential to extend immunotherapy benefits to patient populations unresponsive to current treatments. By concentrating on these innovative approac...
myNEO Therapeutics is a leading biopharmaceutical firm dedicated to pioneering groundbreaking immunotherapies for cancer treatment. Leveraging its ImmunoEngine platform, the company explores unique tumor targets in the dark genome known as camyotopes™. These camyotopes™ hold the potential to extend immunotherapy benefits to patient populations unresponsive to current treatments. By concentrating on these innovative approaches and delving into uncharted territories within the dark genome, myNEO Therapeutics seeks to revolutionize immunotherapy, providing new and effective treatments for a broader range of cancer patients.

List your booth number for exhibitions, ask us